Escalon Medical Corp
ESMC
ESMC was delisted on the 17th of November, 2016.
12 hedge funds and large institutions have $1.4M invested in Escalon Medical Corp in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
31% more capital invested
Capital invested by funds: $1.07M → $1.4M (+$331K)
9% more funds holding
Funds holding: 11 → 12 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$204K |
| 2 |
Renaissance Technologies
New York
|
+$10.1K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$5.1K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$27K |
| 2 |
Citigroup
New York
|
-$1K |
ESMC Hedge Fund Activity: Q2 2014 in Review
12 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Escalon Medical Corp (ESMC) for Q2 2014, worth a combined $1.4M — up 31% from $1.07M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ESMC positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Shepherd Kaplan Krochuk, opening a new position worth an estimated $204K. The largest seller was Citadel Advisors, exiting entirely with an estimated $27K sold.
- 12 institutional investors held Escalon Medical Corp (ESMC) as of Q2 2014, up from 11 in Q1 2014.
- Funds reported $1.4M of Escalon Medical Corp stock for Q2 2014, up 31% quarter-over-quarter.
- 3 funds opened new Escalon Medical Corp positions in Q2 2014 and 2 closed out, a net change of +1 holder.
- The largest Escalon Medical Corp buyer in Q2 2014 was Shepherd Kaplan Krochuk, an estimated $204K added.
- The largest Escalon Medical Corp seller in Q2 2014 was Citadel Advisors, an estimated $27K sold.
Based on aggregated 13F filings for Q2 2014.